Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This study aims to determine how successful the chemotherapy regimen of Pemetrexed plus
cisplatin before surgery is at killing all the tumor so that none is left at the time of
surgery. Following surgery, all eligible patients will receive radiation to the chest. How
patients respond, whether the cancer returns and if so, where, will also be monitored.